{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:58:33Z","timestamp":1761487113036},"reference-count":38,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.jneuroim.2004.01.003","type":"journal-article","created":{"date-parts":[[2004,2,29]],"date-time":"2004-02-29T10:12:04Z","timestamp":1078049524000},"page":"132-138","source":"Crossref","is-referenced-by-count":36,"title":["Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain\u2013Barr\u00e9 patients"],"prefix":"10.1016","volume":"150","author":[{"given":"Karin","family":"Geleijns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart C","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"Van Rijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne P","family":"Tio-Gillen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon D","family":"Laman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter A","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2004.01.003_BIB1","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1086\/344893","article-title":"Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections","volume":"186","author":"Agnese","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB2","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1086\/513783","article-title":"Association between Campylobacter infection and Guillain\u2013Barr\u00e9 syndrome","volume":"176","author":"Allos","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-5728(99)00279-9","article-title":"Campylobacter jejuni lipopolysaccharides from Guillain\u2013Barr\u00e9 syndrome patients induce IgG anti-GM1 antibodies in rabbits","volume":"104","author":"Ang","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB4","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1128\/IAI.69.4.2462-2469.2001","article-title":"Guillain\u2013Barr\u00e9 syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b antibodies in rabbits","volume":"69","author":"Ang","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB5","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1128\/IAI.70.9.5081-5085.2002","article-title":"Ganglioside mimicry of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity in rabbits","volume":"70","author":"Ang","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/76048","article-title":"TLR4 mutations are associated with endotoxin hyporesponsiveness in humans","volume":"25","author":"Arbour","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB7","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1165\/ajrcmb.20.5.3494","article-title":"A Polymorphism* in the 5\u2032 flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E","volume":"20","author":"Baldini","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB9","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.1085536","article-title":"Toll-like receptor signaling pathways","volume":"300","author":"Barton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB10","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1042\/bst0310652","article-title":"Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome","volume":"31","author":"Child","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.410350618","article-title":"Treatment of Guillain\u2013Barr\u00e9 syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study","volume":"35","author":"Dutch Guillain-Barr\u00e9 Study group","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB12","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1161\/01.CIR.99.25.3218","article-title":"C(\u2212260)\u2192T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction","volume":"99","author":"Hubacek","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410400209","article-title":"Campylobacter jejuni infections and anti-GM1 antibodies in Guillain\u2013Barr\u00e9 syndrome","volume":"40","author":"Jacobs","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB15","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain\u2013Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJMoa012673","article-title":"Toll-like receptor 4 polymorphisms and atherogenesis","volume":"347","author":"Kiechl","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/003655202753416867","article-title":"A polymorphism in the CD14 gene is associated with Crohn disease","volume":"37","author":"Klein","year":"2002","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB18","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain\u2013Barr\u00e9 syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0952-7915(03)00080-3","article-title":"Recognition of microbial infection by Toll-like receptors","volume":"15","author":"Kopp","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB20","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.4049\/jimmunol.167.10.5838","article-title":"A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity","volume":"167","author":"LeVan","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB21","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/archinte.162.9.1028","article-title":"Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock","volume":"162","author":"Lorenz","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJM200008033430506","article-title":"Innate immunity","volume":"343","author":"Medzhitov","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-5728(03)00133-4","article-title":"Interleukin-10 promoter polymorphisms in patients with Guillain\u2013Barr\u00e9 syndrome","volume":"139","author":"Myhr","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10048-003-0144-1","article-title":"Immunoglobulin KM genes in Guillain\u2013Barr\u00e9 syndrome","volume":"4","author":"Pandey","year":"2003","journal-title":"Neurogenetics"},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.coi.2003.09.002","article-title":"Toll-like receptors: balancing host resistance with immune tolerance","volume":"15","author":"Pasare","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB25","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1126\/science.1081902","article-title":"Pyogenic bacterial infections in humans with IRAK-4 deficiency","volume":"299","author":"Picard","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1749-6632.1998.tb09683.x","article-title":"Molecular mimicry in Guillain\u2013Barr\u00e9 syndrome","volume":"845","author":"Sheikh","year":"1998","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1471-4906(02)02233-0","article-title":"Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster","volume":"23","author":"Triantafilou","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB28","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/86342","article-title":"A CD14-independent LPS receptor cluster","volume":"2","author":"Triantafilou","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB29","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain\u2013Barr\u00e9 syndrome. Dutch Guillain\u2013Barr\u00e9 Study Group","volume":"326","author":"van der Mech\u00e9","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB30","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1212\/WNL.54.8.1661","article-title":"IgG receptor IIa alleles determine susceptibility and severity of Guillain\u2013Barr\u00e9 syndrome","volume":"54","author":"van der Pol","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/WNL.54.3.620","article-title":"Mild forms of Guillain\u2013Barr\u00e9 syndrome in an epidemiologic survey in The Netherlands","volume":"54","author":"van Koningsveld","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1212\/WNL.58.4.610","article-title":"Infections and course of disease in mild forms of Guillain\u2013Barr\u00e9 syndrome","volume":"58","author":"Van Koningsveld","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB33","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.55.5.705","article-title":"IgG Fc-receptor polymorphisms in Guillain\u2013Barr\u00e9 syndrome","volume":"55","author":"Vedeler","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1212\/WNL.53.3.598","article-title":"Prognostic factors of Guillain\u2013Barr\u00e9 syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain\u2013Barr\u00e9 Study Group","volume":"53","author":"Visser","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2144\/97221pf02","article-title":"The LightCycler: a microvolume multisample fluorimeter with rapid temperature control","volume":"22","author":"Wittwer","year":"1997","journal-title":"BioTechniques"},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB36","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1084\/jem.178.5.1771","article-title":"A bacterium lipopolysaccharide that elicits Guillain\u2013Barr\u00e9 syndrome has a GM1 ganglioside-like structure","volume":"178","author":"Yuki","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2004.01.003_BIB37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0167-5699(93)90212-4","article-title":"CD14: cell surface receptor and differentiation marker","volume":"14","author":"Ziegler-Heitbrock","year":"1993","journal-title":"Immunol. Today"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572804000116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572804000116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T07:57:27Z","timestamp":1585641447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572804000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0165572804000116"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2004.01.003","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}